Query 021456
Match_columns 312
No_of_seqs 186 out of 421
Neff 5.1
Searched_HMMs 29240
Date Mon Mar 25 04:24:41 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/021456.a3m -d /work/01045/syshi/HHdatabase/pdb70.hhm -o /work/01045/syshi/hhsearch_pdb/021456hhsearch_pdb -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 2ki9_A Cannabinoid receptor 2; 63.4 1.1 3.7E-05 27.9 -0.7 21 262-282 3-23 (33)
2 4grv_A Neurotensin receptor ty 41.9 14 0.00048 35.4 2.9 22 261-282 405-426 (510)
3 3vw7_A Proteinase-activated re 26.2 32 0.0011 31.7 2.4 22 261-282 386-407 (484)
4 2rh1_A Beta-2-adrenergic recep 25.9 38 0.0013 32.1 3.0 22 261-282 404-425 (500)
5 4dkl_A MU-type opioid receptor 21.0 56 0.0019 29.7 3.0 22 261-282 379-400 (464)
6 1zx3_A Hypothetical protein NE 19.8 50 0.0017 26.1 2.0 28 1-33 23-50 (122)
7 3v2y_A Sphingosine 1-phosphate 19.1 61 0.0021 30.9 2.9 23 260-282 416-438 (520)
8 3eml_A Human adenosine A2A rec 18.7 67 0.0023 29.4 3.0 22 261-282 391-412 (488)
9 3odu_A C-X-C chemokine recepto 18.5 67 0.0023 29.6 3.0 22 261-282 409-430 (502)
10 4eiy_A Adenosine receptor A2A/ 17.2 77 0.0026 28.6 3.0 22 261-282 350-371 (447)
No 1
>2ki9_A Cannabinoid receptor 2; GPCR, G-protein coupled receptor, membrane protein; NMR {Synthetic}
Probab=63.38 E-value=1.1 Score=27.92 Aligned_cols=21 Identities=33% Similarity=0.556 Sum_probs=17.5
Q ss_pred hHHHHHHHHHHHHHHHHhhhh
Q 021456 262 GVAKLGLTVLGTFTVVWWPYL 282 (312)
Q Consensus 262 rl~~lg~~Vi~tf~l~f~PFl 282 (312)
|..+.-++++++|+++|.|+.
T Consensus 3 k~~k~l~~vv~~F~icW~P~~ 23 (33)
T 2ki9_A 3 RLAKTLGLVLAVLLICWFPVL 23 (33)
T ss_dssp SSSSHHHHHHHHHTTTSSHHH
T ss_pred hhhhhHHHHHHHHHHHHhHHH
Confidence 455677889999999999985
No 2
>4grv_A Neurotensin receptor type 1, lysozyme chimera; G-protein coupled receptor, G-protein, signaling protein-agonist complex; HET: EPE; 2.80A {Rattus norvegicus}
Probab=41.91 E-value=14 Score=35.42 Aligned_cols=22 Identities=27% Similarity=0.505 Sum_probs=20.1
Q ss_pred hhHHHHHHHHHHHHHHHHhhhh
Q 021456 261 HGVAKLGLTVLGTFTVVWWPYL 282 (312)
Q Consensus 261 ~rl~~lg~~Vi~tf~l~f~PFl 282 (312)
+|.++..++|+++|+++|+||.
T Consensus 405 rk~~k~L~iVv~~F~iCWlPf~ 426 (510)
T 4grv_A 405 RHGVLVARAVVIAFVVCWLPYH 426 (510)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHH
Confidence 5789999999999999999985
No 3
>3vw7_A Proteinase-activated receptor 1, lysozyme; high resolution structure, protease-activated receptor 1, in conformation, antagonist vorapaxar; HET: VPX OLC; 2.20A {Homo sapiens}
Probab=26.21 E-value=32 Score=31.70 Aligned_cols=22 Identities=18% Similarity=0.196 Sum_probs=20.5
Q ss_pred hhHHHHHHHHHHHHHHHHhhhh
Q 021456 261 HGVAKLGLTVLGTFTVVWWPYL 282 (312)
Q Consensus 261 ~rl~~lg~~Vi~tf~l~f~PFl 282 (312)
+|.++..++|+++|+++|+|+.
T Consensus 386 ~r~~k~l~~v~~~F~icwlP~~ 407 (484)
T 3vw7_A 386 SRALFLSAAVFCIFIICFGPTN 407 (484)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHH
T ss_pred HHHHHHHHHHHHHHHHHhhHHH
Confidence 6788999999999999999997
No 4
>2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A*
Probab=25.90 E-value=38 Score=32.05 Aligned_cols=22 Identities=36% Similarity=0.770 Sum_probs=20.3
Q ss_pred hhHHHHHHHHHHHHHHHHhhhh
Q 021456 261 HGVAKLGLTVLGTFTVVWWPYL 282 (312)
Q Consensus 261 ~rl~~lg~~Vi~tf~l~f~PFl 282 (312)
+|..+.-++|+++|+++|+||.
T Consensus 404 ~ka~ktl~ivv~~F~icWlP~~ 425 (500)
T 2rh1_A 404 HKALKTLGIIMGTFTLCWLPFF 425 (500)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHH
Confidence 5789999999999999999987
No 5
>4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A*
Probab=20.97 E-value=56 Score=29.66 Aligned_cols=22 Identities=27% Similarity=0.617 Sum_probs=20.6
Q ss_pred hhHHHHHHHHHHHHHHHHhhhh
Q 021456 261 HGVAKLGLTVLGTFTVVWWPYL 282 (312)
Q Consensus 261 ~rl~~lg~~Vi~tf~l~f~PFl 282 (312)
+|..+.-++++++|+++|+|+.
T Consensus 379 ~r~~k~l~~v~~~F~icw~P~~ 400 (464)
T 4dkl_A 379 RRITRMVLVVVAVFIVCWTPIH 400 (464)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhhhHH
Confidence 6899999999999999999986
No 6
>1zx3_A Hypothetical protein NE0241; structural genomics, PSI, prote structure initiative, midwest center for structural genomic unknown function; 2.50A {Nitrosomonas europaea} SCOP: a.43.1.6
Probab=19.77 E-value=50 Score=26.11 Aligned_cols=28 Identities=32% Similarity=0.492 Sum_probs=12.4
Q ss_pred CCchhhhhhhcccccccccccccccceecccCC
Q 021456 1 MGKKKEKKKINEKVDVEAVEIEDDTWWWLTHKG 33 (312)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 33 (312)
|||||.||. .+..|||-...|.++.-.+
T Consensus 23 mgkkknkkt-----evqqpdpmrknwimenmds 50 (122)
T 1zx3_A 23 MGKKKNKKT-----EVQQPDPMRKNWIMENMDS 50 (122)
T ss_dssp --------------CCCCCCCSCCCCCCCSCCH
T ss_pred ccccccccc-----cccCCChhhhhhHHhcccc
Confidence 677766554 4455568788888776544
No 7
>3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A*
Probab=19.14 E-value=61 Score=30.90 Aligned_cols=23 Identities=26% Similarity=0.459 Sum_probs=20.8
Q ss_pred hhhHHHHHHHHHHHHHHHHhhhh
Q 021456 260 IHGVAKLGLTVLGTFTVVWWPYL 282 (312)
Q Consensus 260 ~~rl~~lg~~Vi~tf~l~f~PFl 282 (312)
-+|.++.-++++++|+++|+|+.
T Consensus 416 ~~k~~~~~~~vv~~F~vcw~P~~ 438 (520)
T 3v2y_A 416 NVALLKTVIIVLSVFIACWAPLF 438 (520)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHH
Confidence 45789999999999999999997
No 8
>3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A*
Probab=18.67 E-value=67 Score=29.36 Aligned_cols=22 Identities=27% Similarity=0.498 Sum_probs=20.5
Q ss_pred hhHHHHHHHHHHHHHHHHhhhh
Q 021456 261 HGVAKLGLTVLGTFTVVWWPYL 282 (312)
Q Consensus 261 ~rl~~lg~~Vi~tf~l~f~PFl 282 (312)
+|..+.-++++++|+++|+|+.
T Consensus 391 ~r~~~~l~~iv~~F~icw~P~~ 412 (488)
T 3eml_A 391 VHAAKSLAIIVGLFALCWLPLH 412 (488)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhhhHH
Confidence 6788999999999999999997
No 9
>3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B*
Probab=18.49 E-value=67 Score=29.62 Aligned_cols=22 Identities=23% Similarity=0.531 Sum_probs=20.5
Q ss_pred hhHHHHHHHHHHHHHHHHhhhh
Q 021456 261 HGVAKLGLTVLGTFTVVWWPYL 282 (312)
Q Consensus 261 ~rl~~lg~~Vi~tf~l~f~PFl 282 (312)
+|..+.-++++++|+++|+|+.
T Consensus 409 ~k~~k~l~~vv~~F~icw~P~~ 430 (502)
T 3odu_A 409 RKALKTTVILILAFFACWLPYY 430 (502)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhhhHH
Confidence 7899999999999999999986
No 10
>4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A
Probab=17.17 E-value=77 Score=28.63 Aligned_cols=22 Identities=27% Similarity=0.498 Sum_probs=20.1
Q ss_pred hhHHHHHHHHHHHHHHHHhhhh
Q 021456 261 HGVAKLGLTVLGTFTVVWWPYL 282 (312)
Q Consensus 261 ~rl~~lg~~Vi~tf~l~f~PFl 282 (312)
+|..+.-++++++|+++|+|+.
T Consensus 350 ~r~~k~l~~vv~~F~icw~P~~ 371 (447)
T 4eiy_A 350 VHAAKSLAIIVGLFALCWLPLH 371 (447)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhhhhhheeccHHH
Confidence 5788899999999999999997
Done!